Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations

BRCA1/2Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients

(2014) Gulsah Cecener et al.   CANCER INVESTIGATION

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

(2013) E. C. Inwald et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers

(2013) Anita Bane et al.   BREAST CANCER RESEARCH AND TREATMENT

An International Ki67 Reproducibility Study

(2013) Mei-Yin C. Polley et al.   JNCI-Journal of the National Cancer Institute

MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients

(2012) Mohamed M. Hafez et al.   Asian Pacific Journal of Cancer Prevention

Identification of fifteen novel germline variants in theBRCA13′UTR reveals a variant in a breast cancer case that introduces a functionalmiR-103target site

(2012) Brooke L. Brewster et al.   HUMAN MUTATION

Different methylation and MicroRNA expression pattern in male and female familial breast cancer

(2012) Rosamaria Pinto et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development

(2011) Holger Heyn et al.   INTERNATIONAL JOURNAL OF CANCER

Unknown

(2011) Yingchun Zhao et al.   MOLECULAR MEDICINE

Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer

(2010) Stéphanie Lheureux et al.   BREAST CANCER RESEARCH AND TREATMENT

Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

(2010) Ming Shi et al.   CANCER AND METASTASIS REVIEWS

Microrna let-7: an emerging next-generation cancer therapeutic

(2010) D. Barh et al.   Current Oncology

Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy

(2010) Stuart J Schnitt   MODERN PATHOLOGY

MiRNAs and Cancer

(2009) Rosa Visone et al.   AMERICAN JOURNAL OF PATHOLOGY

Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women

(2009) Tair Kontorovich et al.   INTERNATIONAL JOURNAL OF CANCER

The microRNA network and tumor metastasis

(2009) H Zhang et al.   ONCOGENE

MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary

(2009) Cheng-Han Lee et al.   PLoS One

Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells

(2008) Alexander Marson et al.   CELL

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer

(2008) Marilena V. Iorio et al.   EUROPEAN JOURNAL OF CANCER

Role of microRNAs in drug-resistant ovarian cancer cells

(2008) Antonio Sorrentino et al.   GYNECOLOGIC ONCOLOGY

Novel genetic variants in microRNA genes and familial breast cancer

(2008) Jie Shen et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer

(2008) Jian-Jun Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Small is beautiful: microRNAs and breast cancer-where are we now?

(2008) ET Verghese et al.   JOURNAL OF PATHOLOGY

Endogenous human microRNAs that suppress breast cancer metastasis

(2008) Sohail F. Tavazoie et al.   NATURE

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS